Coronavirus Medicine
-
{
- All
- News
- Videos
-
Cadila Healthcare Explores Biologicals Route To Treat COVID-19, Shares Surge 5%
Zydus Cadila said that its biological therapy Pegylated Interferon alpha-2b, 'PegiHepTM' can emerge as one of the pathways to treat COVID 19.
-
Glenmark To Conduct Clinical Trials For Potential COVID-19 Drug; Shares Surge
Glemark said the approval made it the first pharmaceutical company in India to be given the go-ahead to start trials on COVID-19 patients.
-
Sun Pharma To Test Pancreatitis Drug In COVID-19 Patients
The company joins other drugmakers Glenmark and Strides Pharma Science that are conducting trials in India for potential drugs for COVID-19.
-
Man Caught With 12 Remdesivir Injections In Mumbai
A 22-year-man was caught with a dozen 12 vials of Remdesivir, a key medicine in treatment of coronavirus, in Mumbai, police said on Friday.
-
Ayush Minister Shripad Naik's Reaction To Ramdev's Patanjali's COVID Drug Claims
After the government asked Ramdev's Patanjali Ayurved to stop advertising medicines it launched yesterday as "coronavirus cures" until they are examined, Union Minister Shripad Naik said it is a "good thing" that the yoga teacher has given the country a new medicine but it needs proper permission from his Ayush Ministry. Patanjali sent documents re...
-
Sun Pharma To Test Pancreatitis Drug In COVID-19 Patients
The company joins other drugmakers Glenmark and Strides Pharma Science that are conducting trials in India for potential drugs for COVID-19.
-
Centre Says Medicine Orders Can Be Placed Via WhatsApp, E-Mail
Several Pradhan Mantri Bharatiya Janaushadhi Kendras (PMBJKs) are accepting orders for medicines through WhatsApp and e-mail to ensure easier procurement of medicines by patients during the lockdown, the centre said today.
-
Glenmark To Conduct Clinical Trials For Potential COVID-19 Drug; Shares Surge
Glemark said the approval made it the first pharmaceutical company in India to be given the go-ahead to start trials on COVID-19 patients.
-
Cadila Healthcare Explores Biologicals Route To Treat COVID-19, Shares Surge 5%
Zydus Cadila said that its biological therapy Pegylated Interferon alpha-2b, 'PegiHepTM' can emerge as one of the pathways to treat COVID 19.
-
No Proof Drug Touted By Donald Trump Is Effective Against Coronavirus: EU
The European Commission said on Tuesday there was no evidence that a drug touted by US President Donald Trump as a potential miracle cure against COVID-19 was effective against the disease caused by the new coronavirus.
-
India's Curb On Pharma Export Raises Concern On Coronavirus Drugs Shortage
US health regulators are watching for potential drug shortages after India restricted the export of some raw pharmaceutical ingredients, a move that could disrupt the industry's globe-spanning supply chain.
-
Government Puts Export Curbs On Pharma Ingredients Including Paracetamol Amid Virus Scare
The government on Tuesday put export restrictions on 26 pharma ingredients and medicines, including paracetamol, vitamin B1 and B12, amid the coronavirus outbreak in China, according to a government notification on Tuesday.
-
Cadila Healthcare Explores Biologicals Route To Treat COVID-19, Shares Surge 5%
Zydus Cadila said that its biological therapy Pegylated Interferon alpha-2b, 'PegiHepTM' can emerge as one of the pathways to treat COVID 19.
-
Glenmark To Conduct Clinical Trials For Potential COVID-19 Drug; Shares Surge
Glemark said the approval made it the first pharmaceutical company in India to be given the go-ahead to start trials on COVID-19 patients.
-
Sun Pharma To Test Pancreatitis Drug In COVID-19 Patients
The company joins other drugmakers Glenmark and Strides Pharma Science that are conducting trials in India for potential drugs for COVID-19.
-
Man Caught With 12 Remdesivir Injections In Mumbai
A 22-year-man was caught with a dozen 12 vials of Remdesivir, a key medicine in treatment of coronavirus, in Mumbai, police said on Friday.
-
Ayush Minister Shripad Naik's Reaction To Ramdev's Patanjali's COVID Drug Claims
After the government asked Ramdev's Patanjali Ayurved to stop advertising medicines it launched yesterday as "coronavirus cures" until they are examined, Union Minister Shripad Naik said it is a "good thing" that the yoga teacher has given the country a new medicine but it needs proper permission from his Ayush Ministry. Patanjali sent documents re...
-
Sun Pharma To Test Pancreatitis Drug In COVID-19 Patients
The company joins other drugmakers Glenmark and Strides Pharma Science that are conducting trials in India for potential drugs for COVID-19.
-
Centre Says Medicine Orders Can Be Placed Via WhatsApp, E-Mail
Several Pradhan Mantri Bharatiya Janaushadhi Kendras (PMBJKs) are accepting orders for medicines through WhatsApp and e-mail to ensure easier procurement of medicines by patients during the lockdown, the centre said today.
-
Glenmark To Conduct Clinical Trials For Potential COVID-19 Drug; Shares Surge
Glemark said the approval made it the first pharmaceutical company in India to be given the go-ahead to start trials on COVID-19 patients.
-
Cadila Healthcare Explores Biologicals Route To Treat COVID-19, Shares Surge 5%
Zydus Cadila said that its biological therapy Pegylated Interferon alpha-2b, 'PegiHepTM' can emerge as one of the pathways to treat COVID 19.
-
No Proof Drug Touted By Donald Trump Is Effective Against Coronavirus: EU
The European Commission said on Tuesday there was no evidence that a drug touted by US President Donald Trump as a potential miracle cure against COVID-19 was effective against the disease caused by the new coronavirus.
-
India's Curb On Pharma Export Raises Concern On Coronavirus Drugs Shortage
US health regulators are watching for potential drug shortages after India restricted the export of some raw pharmaceutical ingredients, a move that could disrupt the industry's globe-spanning supply chain.
-
Government Puts Export Curbs On Pharma Ingredients Including Paracetamol Amid Virus Scare
The government on Tuesday put export restrictions on 26 pharma ingredients and medicines, including paracetamol, vitamin B1 and B12, amid the coronavirus outbreak in China, according to a government notification on Tuesday.
